The predictive ability of serum α‐fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance

作者: Teh-Ia Huo , Cheng-Yuan Hsia , Chi-Jen Chu , Yi-Hsiang Huang , Wing-Yiu Lui

DOI: 10.1002/JSO.20653

关键词:

摘要: Background Serum α-fetoprotein (AFP) is the most important tumor marker for hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP HCC widely varied. This study investigated factors contributory to heterogeneity ability detect HCC. Methods A total 1,135 patients were categorized into four groups: undergoing surgical resection (n = 248), chronic hepatitis B (CHB, n = 413), C (CHC, n = 207), and liver cirrhosis (LC, n = 267). area under receiver operating characteristic curve (AUC) was estimated in different combinations. Results The AUC highest when co-analyzed with LC (0.805), followed by co-analyzing CHB (0.797) CHC (0.740). optimal cutoffs between 26 32 ng/ml. Patients size ≤3 cm had a lower positive value (PPV, 30%) compared >3 (46%), HBsAg-negative anti-HCV-positive lowest PPV (38%) other groups (60%, 100%, 82%) at cutoff 20 B-negative subjects (0.684 0.509), B-positive (0.826 0.806) stratified status HCV. Elevated ALT >80 U/L independently predicted increased (>20 ng/ml) levels. Conclusions Serum fairly stable HCC, an around 30 level, viral status, may significantly confound its HCC. J. Surg. Oncol. 2007;95:645–651. © 2007 Wiley-Liss, Inc.

参考文章(33)
Roberta Sesti, Silvio Tripi, Giulio Bonfissuto, Antonio Carroccio, Gaetano Leto, Giuseppe Montalto, Maurizio Soresi, Carmela Magliarisi, Anna Riili, Pietro Campagna, Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Research. ,vol. 23, pp. 1747- 1753 ,(2003)
Hiroko Taga, Shinji Satomura, Kazuhisa Taketa, Hidematsu Hirai, Tadashi Kawai, Shuji Matsuura, Toshihiko Koji, Chihiro Sekiya, Kyuichi Tanikawa, Yasuo Endo, A Collaborative Study for the Evaluation of Lectin-Reactive α-Fetoproteins in Early Detection of Hepatocellular Carcinoma Cancer Research. ,vol. 53, pp. 5419- 5423 ,(1993)
Jen-Hao Chen, Gar-Yang Chau, Wing-Yiu Lui, Shyh-Haw Tsay, Kuang-Liang King, Che-Chuan Loong, Cheng-Yuan Hsia, Chew-Wen Wu, Surgical Results in Patients with Hepatitis B-related Hepatocellular Carcinoma and Positive Hepatitis B Early Antigen World Journal of Surgery. ,vol. 24, pp. 383- 388 ,(2000) , 10.1007/S002689910061
Fumio Nomura, Michikuni Ishijima, Katsuhiko Kuwa, Naomi Tanaka, Toshiaki Nakai, Kunihiko Ohnishi, Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. The American Journal of Gastroenterology. ,vol. 94, pp. 650- 654 ,(1999) , 10.1111/J.1572-0241.1999.00930.X
Morris Sherman, Alphafetoprotein: an obituary. Journal of Hepatology. ,vol. 34, pp. 603- 605 ,(2001) , 10.1016/S0168-8278(01)00025-3
Ke-Qin Hu, Namgyal L. Kyulo, Nelson Lim, Brijie Elhazin, Donald J. Hillebrand, Tracy Bock, Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. The American Journal of Gastroenterology. ,vol. 99, pp. 860- 865 ,(2004) , 10.1111/J.1572-0241.2004.04152.X
Adrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, James E Everhart, Jules L Dienstag, Herbert L Bonkovsky, Elizabeth C Wright, Gregory T Everson, Karen L Lindsay, Anna SF Lok, William M Lee, Timothy R Morgan, Marc G Ghany, David R Gretch, HALT-C Trial Group, None, Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial Journal of Hepatology. ,vol. 43, pp. 434- 441 ,(2005) , 10.1016/J.JHEP.2005.03.019
Teh-Ia Huo, Yi-Hsiang Huang, Wing-Yiu Lui, Jaw-Ching Wu, Pui-Ching Lee, Full-Young Chang, Shou-Dong Lee, Selective prognostic impact of serum α-fetoprotein level in patients with hepatocellular carcinoma: Analysis of 543 patients in a single center Oncology Reports. ,vol. 11, pp. 543- 550 ,(2004) , 10.3892/OR.11.2.543
Keiko Urata, Takashi Matsumata, Tatsuro Kamakura, Kanehiro Hasuo, Keizo Sugimachi, Lipiodolization for unresectable hepatocellular carcinoma: An analysis of 205 patients using univariate and multivariate analysis Journal of Surgical Oncology. ,vol. 56, pp. 54- 58 ,(1994) , 10.1002/JSO.2930560113
Francesco Izzo, Francesco Cremona, Paolo Delrio, Enrico Leonardi, Giuseppe Castello, Sandro Pignata, Bruno Daniele, Steven A. Curley, Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Annals of Surgical Oncology. ,vol. 6, pp. 178- 185 ,(1999) , 10.1007/S10434-999-0178-1